In male rodents, androgens, by regulating genes involved in hepatic lipogenesis and glucose metabolism, protect from NAFLD and insulin resistance through a dual mechanism: via androgen receptor signaling and via estrogen receptor signaling (following aromatization of testosterone to estradiol) [169]. This evidence concerns the gene AR and metabolic dysfunction-associated steatotic liver disease.